本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Eterna Therapeutics Inc.

4.60
+0.33007.73%
成交量:48.36萬
成交額:202.77萬
市值:750.90萬
市盈率:-0.25
高:4.70
開:3.78
低:3.65
收:4.27
52周最高:71.50
52周最低:3.18
股本:163.24萬
流通股本:120.27萬
量比:80.44
換手率:40.21%
股息:- -
股息率:- -
每股收益(TTM):-18.6059
每股收益(LYR):-55.8903
淨資產收益率:-320.72%
總資產收益率:-105.57%
市淨率:2.35
市盈率(LYR):-0.08

資料載入中...

2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/03

重要事件披露

Form 8-K - Current report
2026/07/03

重要事件披露

Form 8-K - Current report
2026/06/26

重要事件披露

Form 8-K - Current report
2026/05/20

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/04

重要事件披露

Form 8-K - Current report
2026/03/27

SEC問詢函

Form CORRESP - Correspondence
2026/03/20

重要事件披露

Form 8-K - Current report
2026/03/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/11

重要事件披露

Form 8-K - Current report
2026/02/05

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/02/04

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/02/04

SEC問詢函

Form CORRESP - Correspondence